Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer

Recruiting

Phase 1

IMRT with Carboplatin & PaclitaxelRadiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer

Sponsor:

Washington University School of Medicine

Code:

NCT04046575

Conditions

Esophagus Cancer

Esophageal Cancer

Cancer of the Esophagus

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Intensity Modulated Radiation Therapy

Carboplatin

MD Anderson Symptom Inventory (MDASI)-Plus module

EuroQol (EQ-5D)

SF-12

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Washington University School of Medicine on 2024-12-03.